Document detail
ID

oai:pubmedcentral.nih.gov:8879...

Topic
Themed Section: Neurodegenerative ...
Author
Banerjee, Rajashree Rai, Arushi Iyer, Shreyas M. Narwal, Sonia Tare, Meghana
Langue
en
Editor

John Wiley and Sons Inc.

Category

Animal Models and Experimental Medicine

Year

2022

listing date

10/16/2023

Keywords
parkinson alzheimer models disease
Metrics

Abstract

Alzheimer's disease and Parkinson's disease are two of the most prevalent and disabling neurodegenerative diseases globally.

Both are proteinopathic conditions and while occasionally inherited, are largely sporadic in nature.

Although the advances in our understanding of the two have been significant, they are far from complete and neither diagnosis nor the current practices in treatment and rehabilitation is adequately helpful.

Animal models have historically found application as testing beds for novel therapeutics and continue to be valuable aids in pharmacological research.

This review chronicles the development of those models in the context of Alzheimer's and Parkinson's disease, and highlights the shifting paradigms in studying two human‐specific conditions in non‐human organisms.

Banerjee, Rajashree,Rai, Arushi,Iyer, Shreyas M.,Narwal, Sonia,Tare, Meghana, 2022, Animal models in the study of Alzheimer's disease and Parkinson's disease: A historical perspective, John Wiley and Sons Inc.

Document

Open Open

Share

Source

Articles recommended by ES/IODE AI

High-Frequency Repetitive Magnetic Stimulation at the Sacrum Alleviates Chronic Constipation in Parkinson’s Patients
magnetic stimulation parkinson’s significant patients scale sacrum pd hf-rms chronic constipation scores
The mechanism of PFK-1 in the occurrence and development of bladder cancer by regulating ZEB1 lactylation
bladder cancer pfk-1 zeb1 lactylation glycolysis inhibits lactate glucose bc pfk-1 cancer lactylation cells bladder